ArticlePublisher preview availableLiterature Review

Predictive, Personalized, Preventive and Participatory (4P) Medicine Applied to Telemedicine and eHealth in the Literature

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract and Figures

Objective: The main objective of this work is to provide a review of existing research work into predictive, personalized, preventive and participatory medicine in telemedicine and health. Methods: The academic databases used for searches are IEEE Xplore, PubMed, Science Direct, Web of Science and ResearchGate, taking into account publication dates from 2010 up to the present day. These databases cover the greatest amount of information on scientific texts in multidisciplinary fields, from engineering to medicine. Various search criteria were established, such as ("Predictive" OR "Personalized" OR "Preventive" OR "Participatory") AND "Medicine" AND ("Health" OR "Telemedicine") selecting the articles of most interest. Results: A total of 184 publications about predictive, personalized, preventive and participatory (4P) medicine in telemedicine and health were found, of which 48 were identified as relevant. Many of the publications found show how the P4 medicine is being developed in the world and the benefits it provides for patients with different illnesses. Conclusion: After the revision that was undertaken, it can be said that P4 medicine is a vital factor for the improvement of medical services. It is hoped that one of the main contributions of this study is to provide an insight into how P4 medicine in telemedicine and health is being applied, as well as proposing outlines for the future that contribute to the improvement of prevention and prediction of illnesses.
This content is subject to copyright. Terms and conditions apply.
SYSTEMS-LEVEL QUALITY IMPROVEMENT
Predictive, Personalized, Preventive and Participatory (4P) Medicine
Applied to Telemedicine and eHealth in the Literature
Susel Góngora Alonso
1
&Isabel de la Torre Díez
1
&Begoña García Zapiraín
2
Received: 28 January 2019 / Accepted: 5 April 2019 /Published online: 12 April 2019
#Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract
The main objective of this work is to provide a review of existing research work into predictive, personalized, preventive and
participatory medicinein telemedicine and ehealth. The academic databases used for searches are IEEE Xplore, PubMed, Science
Direct, Web of Science and ResearchGate, taking into account publication dates from 2010 up to the present day. These databases
cover the greatest amount of information on scientific texts in multidisciplinary fields, from engineering to medicine. Various
search criteria were established, such as (BPredictive^OR BPersonalized^OR BPreventive^OR BParticipatory^) AND
BMedicine^AND (BeHealth^OR BTelemedicine^) selecting the articles of most interest. A total of 184 publications about
predictive, personalized, preventive and participatory (4P) medicine in telemedicine and ehealth were found, of which 48 were
identifiedas relevant. Many of the publications found show how the P4 medicine is being developed in the world and the benefits
it provides for patients with different illnesses. After the revision that was undertaken, it can be said that P4 medicine is a vital
factor for the improvement of medical services. It is hoped that one of the main contributions of this study is to provide an insight
into how P4 medicine in telemedicine and ehealth is being applied, as well as proposing outlines for the future that contribute to
the improvement of prevention and prediction of illnesses.
Keywords eHealth .Predictive .Personalized .Preventive .Participatory .Teleme dicine
Introduction
P4 medicine describes a focus on systems that include predic-
tive, personalized, preventive and participative aspects [1]. It
proposes the integration of numerous points of biological data,
which include longitudinal molecular, cellular and phenotypical
measurements, as well as individual genome sequences, in or-
der to better define the health or wellbeing of every person,
predict transitions to illness and orient medical interventions
[2,3]. The implementation of P4 medicine from a clinical point
of view will create predictive and personalized models that
represent the wellbeing of every patient or of a disease, which
enables the design of new pharmacological tests that take into
account the heterogeneity of responses to therapies and the
stratification of the illness [4,5].
Computer technology has been applied to various domains
in order to obtain a greater yield. From the point of view of
preventive medicine, portable devices are useful for monitor-
ing and warning. Building a software system that facilitates
monitoring and warning is one promising solution for promot-
ingpreventivemedicine[6,7].
Thefutureofhealthservicesiscenteredonofferingpeople
a complete image of the many factors that affect their health.
Real-time analysis enables doctors, researchers and other in-
terested parties to take the most informed decisions, at the
same tame as offering patients greater control over their own
medical attention [8,9]. Cognitive computing constitutes a
new evolution of algorithms and systems with language-
This article is part of the Topical Collection on Systems-Level Quality
Improvement
*Isabel de la Torre Díez
isator@tel.uva.es
Susel Góngora Alonso
suselgongoraalonso@gmail.com
Begoña García Zapiraín
mbgarciazapi@deusto.es
1
Department of Signal Theory and Communications, and Telematics
Engineering, University of Valladolid, Paseo de Belén, 15,
47011 Valladolid, Spain
2
University of Deusto, Avenida de las Universidades 24,
48007 Bilbao, Spain
Journal of Medical Systems (2019) 43: 140
https://doi.org/10.1007/s10916-019-1279-4
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
... Stakeholders may confirm the accuracy and explainability of the predictive analytics process by documenting every stage of an ML model's lifespan on the Blockchain, including data preparation, model training, updates, and predictions. This capacity is vital in the healthcare industry, where trust and responsibility are crucial (Alonso et al., 2019). By better understanding these underlying technologies, researchers and practitioners may use their combined talents more effectively to meet the challenges of precision medicine. ...
Article
Full-text available
This research integrates Blockchain and machine learning (ML) for precision medicine predictive analytics to solve data privacy, security, interoperability, and trust issues. Secondary data from peer-reviewed publications, case studies, and technical reports are reviewed to examine blockchain-enhanced ML's potential and limits in healthcare. Researchers found that Blockchain increases data integrity, secure data sharing, and ML model transparency, boosting healthcare stakeholder trust and cooperation. Privacy rules like GDPR and HIPAA are met while the connection allows individualized treatment recommendations, early illness identification, and enhanced clinical trials. According to the report, scalability, legacy system integration, and regulatory difficulties hinder adoption. Policy implications emphasize the need for clear legislative frameworks that balance innovation and privacy and promote stakeholder engagement to address these challenges. This research sheds light on how Blockchain and ML may be used synergistically to enhance precision medicine and provide more secure, transparent, and effective healthcare solutions.
... The second step is to promote the implementation of 4P medicine (predictive, preventive, personalized and participatory), that is, the medical consultation should not focus on the symptoms, but rather, through predictive medicine, genes and allelic variants that predict chronic diseases would be identified; through preventive medicine, foods that activate these genes would be avoided; and if medication is required, personalized pharmacological treatment would be initiated based on the metabolic genotype/phenotype (personalized or precision medicine); and with the participation of biochemists, pharmacists, nurses, patient and treating doctor (participatory medicine) adherence to the prevention and treatment of the disease would be achieved (Alonso et al. 2019;Slim et al. 2021). The third step is to carry out relative bioavailability studies of generic and similar medicines (medicines manufactured by different laboratories with commercial names) to obtain bioequivalent medicines and in clinical practice demonstrate therapeutic interchangeability. ...
Article
Full-text available
High-flow non-invasive ventilation (NIV) devices reduce the morbidity and mortality of COVID-19. The objective was to evaluate the use of the non-invasive ventilation device with high-flow helmet CPAP designed in Peru in patients with severe acute respiratory syndrome (COVID-19) hospitalized in the emergency services of five hospitals. Prospective multicenter and cross-sectional observational study from five hospitals from July to August 2020. 19 patients were recruited and divided into two groups (G-1 n = 10; G-2 n = 9) applying clinical and gasometric parameters as indicators of disease evolution upon hospital admission and within 24 hours. A progressive increase in these parameters was observed in those patients who used the NIVCPAP helmet within the first 24 hours. In G-01, improvement was evident in 90% (n = 9/10): PaO2 (range 48–137; average: 82.49 ± 8.07; p-value = 0.008), CO2 (25.2–51.0; 36.62 ± 2.62; p-value p = 0.327), and the PaO2/FiO2 coefficient (87–318; 191.5 ± 18.68). 10% of patients did not progress optimally, being subjected to endotracheal intubation and invasive mechanical ventilation. In G-02 the values were %SatO2 (range 92–98; 96 ± 0.76) and the SaO2/FiO2 coefficient (214–228; 223.2 ± 1.80), indicating significant improvement within 24 hours (p < 0.001). It is concluded that the use of the CPAP helmet non-invasive ventilation (NIV) device contributes to improving gasometric values and clinical condition. Being an alternative to recover typical cases of COVID-19 in all hospitals in Peru.
... Personal health data are a valuable resource that significantly impacts biomedical research and digital health ecosystems [2]. The integration of sophisticated technologies with the widespread use of personal health data has resulted in groundbreaking work within the realm of medicine and tangible applications in the health care sector [3]. However, the combination of technology and personal health data has led to concerns associated with data privacy and security, as well as ethical implications in terms of consent and potential exploitation [4,5]. ...
Article
Full-text available
Background The principles of dynamic consent are based on the idea of safeguarding the autonomy of individuals by providing them with personalized options to choose from regarding the sharing and utilization of personal health data. To facilitate the widespread introduction of dynamic consent concepts in practice, individuals must perceive these procedures as useful and easy to use. This study examines the user experience of a dynamic consent-based application, in particular focusing on personalized options, and explores whether this approach may be useful in terms of ensuring the autonomy of data subjects in personal health data usage. Methods This study investigated the user experience of MyHealthHub, a dynamic consent-based application, among adults aged 18 years or older living in South Korea. Eight tasks exploring the primary aspects of dynamic consent principles–including providing consent, monitoring consent history, and managing personalized options were provided to participants. Feedback on the experiences of testing MyHealthHub was gathered via multiple-choice and open-ended questionnaire items. Results A total of 30 participants provided dynamic consent through the MyHealthHub application. Most participants successfully completed all the provided tasks without assistance and regarded the personalized options favourably. Concerns about the security and reliability of the digital-based consent system were raised, in contrast to positive responses elicited in other aspects, such as perceived usefulness and ease of use. Conclusions Dynamic consent is an ethically advantageous approach for the sharing and utilization of personal health data. Personalized options have the potential to serve as pragmatic safeguards for the autonomy of individuals in the sharing and utilization of personal health data. Incorporating the principles of dynamic consent into real-world scenarios requires remaining issues, such as the need for powerful authentication mechanisms that bolster privacy and security, to be addressed. This would enhance the trustworthiness of dynamic consent-based applications while preserving their ethical advantages.
Article
The 3PM framework revolutionizes disease management by facilitating early risk prediction, disease prevention, and personalized treatment. For isolated incomplete lateral meniscal injuries (IILMI), where early diagnosis is challenging due to non-specific symptoms, 3PM’s proactive approach is beneficial in preventing knee joint disease progression and maintaining patients’ quality of life. This study aimed to develop a predictive model within the 3PM framework, integrating knee MRI anatomical features with individual physical activity (PA) patterns to enhance early IILMI detection and treatment efficacy, improving patient outcomes and quality of life. The training dataset comprised 254 patients. Using logistic regression analyses and least absolute shrinkage and selection operator (LASSO), IILMI was identified among various preoperative factors containing knee MRI and PA features. A dynamic nomogram was constructed and subjected to internal and external validations (91 patients). Validation encompassed C-index, receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis (DCA), and clinical impact curves. ROC analysis determined the risk stratification cut-off. Six independent IILMI factors were identified, including PA intensity, PA type, degree of PA intensity, and MRI-derived anatomical parameters. The dynamic nomogram showed high predictive accuracy (C-index, 0.829 in training, 0.906 in validation). IILMI patients were divided into low-risk, medium-risk, and high-risk groups according to the cut-off value. In 3PM-guided management, the dynamic nomogram enables early IILMI diagnosis in patients while promoting IILMI stratification making personalized treatment feasible. With further development, it holds promise for effectively predicting IILMI risk, preventing severe knee pathologies, and enhancing the quality of life for at-risk patients.
Article
PURPOSE Thyroid nodules are common in the general population, and assessing their malignancy risk is the initial step in care. Surgical exploration remains the sole definitive option for indeterminate nodules. Extensive database access is crucial for improving this initial assessment. Our objective was to develop an automated process using convolutional neural networks (CNNs) to extract and structure biomedical insights from electronic health reports (EHRs) in a large thyroid pathology cohort. MATERIALS AND METHODS We randomly selected 1,500 patients with thyroid pathology from our cohort for model development and an additional 100 for testing. We then divided the cohort of 1,500 patients into training (70%) and validation (30%) sets. We used EHRs from initial surgeon visits, preanesthesia visits, ultrasound, surgery, and anatomopathology reports. We selected 42 variables of interest and had them manually annotated by a clinical expert. We developed RUBY-THYRO using six distinct CNN models from SpaCy, supplemented with keyword extraction rules and postprocessing. Evaluation against a gold standard database included calculating precision, recall, and F1 score. RESULTS Performance remained consistent across the test and validation sets, with the majority of variables (30/42) achieving performance metrics exceeding 90% for all metrics in both sets. Results differed according to the variables; pathologic tumor stage score achieved 100% in precision, recall, and F1 score, versus 45%, 28%, and 32% for the number of nodules in the test set, respectively. Surgical and preanesthesia reports demonstrated particularly high performance. CONCLUSION Our study successfully implemented a CNN-based natural language processing (NLP) approach for extracting and structuring data from various EHRs in thyroid pathology. This highlights the potential of artificial intelligence-driven NLP techniques for extensive and cost-effective data extraction, paving the way for creating comprehensive, hospital-wide data warehouses.
Article
Full-text available
Introdução: a hanseníase é uma doença infectocontagiosa causada pela bactéria Mycobacterium leprae, permanecendo importante causa de morbimortalidade em países como Índia, Brasil e Indonésia. Objetivo: realizar um mapeamento sistemático das pesquisas primárias disponíveis na literatura sobre o uso de ferramentas tecnológicas aplicadas no campo da hanseníase. Metodologia: a questão de pesquisa foi: “Quais ferramentas existem para estudo remoto da hanseníase?”. Aplicou-se estratégia de busca específica nas bases PubMed, Scopus e Web of Science, tendo sido incluídos todos os artigos científicos publicados em inglês, português ou espanhol, no período entre 2015 e 2021, e que estivessem no escopo da pesquisa. Os dados foram extraídos com uso de questionário estruturado e avaliou-se o risco de viés dos estudos incluídos. Resultados: a metodologia empregada permitiu a seleção de 15 artigos científicos. Predominaram estudos realizados no Brasil, na Índia e na Indonésia, indexados no PubMed e publicados entre 2020 e 2021. Os estudos avaliados mostraram o uso de ferramentas tecnológicas na hanseníase nas mais diversas plataformas, com resultados promissores para a saúde primária, condução dos casos e pesquisa. Contudo, ainda de forma incipiente. Conclusão: este mapeamento sistemático indica a necessidade de mais estudos, com maior robustez, acerca do uso de ferramentas tecnológicas no enfrentamento da hanseníase em nível de saúde e pesquisa.
Conference Paper
Full-text available
Studies suggest that a significant proportion of the diagnosis in non-communicable diseases (NCD) is erroneous, unwanted, or unnecessary. To reduce the disease burden and improve public health, algorithmic support is essential. To realize this, health data must be computer understandable, secured, ubiquitous, and interoperable. Medical and disease data entered into computers are unstructured natural language texts with medical jargons which a computer normally cannot understand. EMR (Electronic Medical Records) are data silos in the hospital and do not interoperate. In this paper we present Ethereum based future ready Proof of Disease (PoD) consensus protocol with a computer understandable single instance of truth. It will solve many challenges that electronic health records (EHR) or health information exchange (HIE) have failed to address. This medical system will help achieve all the complex needs of P6 (Participatory, Personalized, Proactive, Preventive, Predictive and Precision) medicine and finally reduce the disease burden.
Article
Full-text available
Personalized medicine is an aspect of the P4 medicine (predictive, preventive, personalized and participatory) based precisely on the customization of all medical characters of each subject. In personalized medicine, the development of medical treatments and drugs is tailored to the individual characteristics and needs of each subject, according to the study of diseases at different scales from genotype to phenotype scale. To make concrete the goal of personalized medicine, it is necessary to employ high-throughput methodologies such as Next Generation Sequencing (NGS), Genome-Wide Association Studies (GWAS), Mass Spectrometry or Microarrays, that are able to investigate a single disease from a broader perspective. A side effect of high-throughput methodologies is the massive amount of data produced for each single experiment, that poses several challenges (e.g., high execution time and required memory) to bioinformatic software. Thus a main requirement of modern bioinformatic softwares, is the use of good software engineering methods and efficient programming techniques, able to face those challenges, that include the use of parallel programming and efficient and compact data structures. This paper presents the design and the experimentation of a comprehensive software pipeline, named microPipe, for the preprocessing, annotation and analysis of microarray-based Single Nucleotide Polymorphism (SNP) genotyping data. A use case in pharmacogenomics is presented. The main advantages of using microPipe are: the reduction of errors that may happen when trying to make data compatible among different tools; the possibility to analyze in parallel huge datasets; the easy annotation and integration of data. microPipe is available under Creative Commons license, and is freely downloadable for academic and not-for-profit institutions.
Article
Full-text available
Human health and disease are emergent properties of a complex, nonlinear, dynamic multilevel biological system: the human body. Systems biology is a comprehensive research strategy that has the potential to understand these emergent properties holistically. It stems from advancements in medical diagnostics, "omics" data and bioinformatic computing power. It paves the way forward towards "P4 medicine" (predictive, preventive, personalised and participatory), which seeks to better intervene preventively to preserve health or therapeutically to cure diseases. In this review, we: 1) discuss the principles of systems biology; 2) elaborate on how P4 medicine has the potential to shift healthcare from reactive medicine (treatment of illness) to predict and prevent illness, in a revolution that will be personalised in nature, probabilistic in essence and participatory driven; 3) review the current state of the art of network (systems) medicine in three prevalent respiratory diseases (chronic obstructive pulmonary disease, asthma and lung cancer); and 4) outline current challenges and future goals in the field.
Article
Full-text available
Women's evolution for nurturing and fat accumulation, which historically yielded health and longevity advantages against scarcity, may now be counteracted by increasing risks in the obesogenic environment, recently shown by narrowing gender health gap. Women's differential metabolism/disease risks, i.e. in fat accumulation/distribution, exemplified during puberty/adolescence, suggest gender dimorphism with obesity outcomes. Women's higher body fat percentage than men, even with equal body mass index, may be a better risk predictor. Differential metabolic responses to weight-reduction diets, with women's lower abdominal fat loss, better response to high-protein vs. high-carbohydrate diets, higher risks with sedentariness vs. exercise benefits, and tendency toward delayed manifestation of central obesity, metabolic syndrome, diabetes, cardiovascular disease, and certain cancers until menopause-but accelerated thereafter-suggest a need for differing metabolic and chronological perspectives for prevention/intervention. These perspectives, including women's differential responses to lifestyle changes, strongly support further research with a gender nutrition emphasis within predictive, preventive, and personalized medicine.
Article
Full-text available
Clinical assessment in psychiatry is commonly based on findings from brief, regularly scheduled in-person appointments. Although critically important, this approach reduces assessment to cross-sectional observations that miss essential information about disease course. The mental health provider makes all medical decisions based on this limited information. Thanks to recent technological advances such as mobile phones and other personal devices, electronic health (eHealth) data collection strategies now can provide access to real-time patient self-report data during the interval between visits. Since mobile phones are generally kept on at all times and carried everywhere, they are an ideal platform for the broad implementation of ecological momentary assessment technology. Integration of these tools into medical practice has heralded the eHealth era. Intelligent health (iHealth) further builds on and expands eHealth by adding novel built-in data analysis approaches based on (1) incorporation of new technologies into clinical practice to enhance real-time self-monitoring, (2) extension of assessment to the patient's environment including caregivers, and (3) data processing using data mining to support medical decision making and personalized medicine. This will shift mental health care from a reactive to a proactive and personalized discipline.
Article
Full-text available
Precision (P4) medicine represents a new medical paradigm that focuses on Personalized, Predictive, Preventive and Participatory approaches. The P4 paradigm is particularly appropriate for moving the care of persons with myopenia forward. Muscular dystrophies are clearly a set of genetically different diseases where genomics are the basis of diagnosis, and genetic modulation via DNA, oligonucleotides and clustered regularly interspaced short palendronic repeats hold great potential for a cure. The utility of personalized genomics for sarcopenia coupled with utilizing a predictive approach for the diagnosis with early preventive strategies is a key to improving sarcopenic outcomes. The importance of understanding different levels of patient enthusiasm and different responses to exercise should guide the participatory phase of sarcopenic treatment. In the case of cachexia, understanding the effects of the different therapies now available through the P4 approach on muscle wasting is a key to management strategies.
Article
Medicine is undergoing a revolution that is even transforming the nature of health care from reactive to proactive. To serve these new and diverse needs, bioinformatics and data mining are teaming up to generate tools and procedures for prediction of disease recurrence and progression, response to treatment, as well as new insights into various oncogenic pathways by taking into account the user needs and their heterogeneity. The p-medicine consortium (http://www.p-medicine.eu) is creating a biomedical platform to facilitate the translation from current practice to a predictive, personalized, preventive, participatory and psycho-cognitive medicine by integrating VPH models, clinical practice, imaging and omics data. In this paper, we present the challenges for data mining based analysis in bio- and medical informatics and our approach towards a data mining environment addressing these requirements in the p-medicine platform.
Article
Hippocrates was the first to raise awareness of medicine as a science. He asserted the body being a unified whole and emphasized the importance of preventive and predictive medicine, spurring physicians to foster patient collaboration. Recent achievements today have permitted a new approach "P4 medicine" - Predictive, Preventive, Personalized and Participatory - with the aim of depicting an individual's health history and molecular profile in determining the best medical intervention in maintaining or restoring wellbeing. There is a link, which brings together Hippocrates and P4 Medicine. This review will elaborate further this statement, considering the scientific achievements that paved the way for recent medical approaches. Emphasis will be given to the social impact of new diagnostic and therapeutic protocols, considering their costs and their success probabilities.
Article
Recent research has shown that the microbiome-a collection of microorganisms, including bacteria, fungi, and viruses, living on and in a host-are of extraordinary importance in human health, even from conception and development in the uterus. Therefore, to further our ability to diagnose disease, to predict treatment outcomes, and to identify novel therapeutics, it is essential to include microbiome and microbial metabolic biomarkers in Systems Biology investigations. In clinical studies or, more precisely, Systems Medicine approaches, we can use the diversity and individual characteristics of the personal microbiome to enhance our resolution for patient stratification. In this review, we explore several Systems Medicine approaches, including Microbiome Wide Association Studies to understand the role of the human microbiome in health and disease, with a focus on 'preventive medicine' or P4 (i.e., personalized, predictive, preventive, participatory) medicine.